Material to categorize
- Yaygın Görülen Nörolojik Hastalıklarda Tamamlayıcı ve Alternatif Tıp Kullanımı.Tugba Gürel - 2020 - Ankara, Türkiye: Gece.details
- “First, Do No Harm”: Physician Discretion, Racial Disparities, and Opioid Treatment Agreements.Adrienne Beck, Larisa Svirsky & Dana Howard - forthcoming - Journal of Medical Ethics.details
- Why We Should Stop Using Animal-Derived Products on Patients Without Their Consent.Daniel Rodger - forthcoming - Journal of Medical Ethics.details
- Coercion in the Recruitment and Retention of Human Research Subjects, Pharmaceutical Industry Payments to Physician-Investigators and the Moral Courage of the IRB.Evan G. DeRenzo - 2000 - IRB: Ethics & Human Research 22 (2):1.details
- On Drugs.Sam Baron, Sara Linton & Maureen O'Malley - forthcoming - Journal of Medicine and Philosophy.details
- Drugs on the Page: Pharmacopoeias and Healing Knowledge in the Early Modern Atlantic World, Edited by Matthew James Crawford and Joseph M. Gabriel, 2019.Jole Shackelford - 2020 - Early Science and Medicine 25 (1):80-84.details
- Lowering Restrictions on Performance Enhancing Drugs in Elite Sports.Rory Warwick Collins - 2017 - Inquiries Journal 9 (3).details
- Applied Mysticism: A Drug‐Enabled Visionary Experience Against Moral Blindness.Virginia Ballesteros - 2019 - Zygon 54 (3):731-755.details
- Ethics, Collectives, and Drugs.Arthur C. Petersen - 2019 - Zygon 54 (3):553-556.details
- Ethics and Drug Testing in Human Beings.Joseph Mahon - 1987 - Royal Institute of Philosophy Lectures 22:199-211.details
- Adolescent and Parent Perspectives on Ethical Issues in Youth Drug Use and Suicide Survey Research.Celia B. Fisher - 2003 - Ethics and Behavior 13 (4):303-332.details
- Key Opinion Leaders and Pediatric Antidepressant Overprescribing.Jon Jureidini & Leemon McHenry - 2009 - Psychotherapy and Psychosomatics 78:197-201.details
- On the Origin of Great Ideas: Science in the Age of Big Pharma.Leemon B. McHenry - 2005 - Hastings Center Report 35 (6):17-19.details
- Industry-Corrupted Psychiatric Trials.Leemon McHenry, Jon Jureidini & Jay Amsterdam - 2017 - Psychiatria Polska 51 (6):993-1008.details
- The Citalopram CIT-MD-18 Pediatric Depression Trial: A Deconstruction of Medical Ghostwriting, Data Manipulation and Academic Malfeasance.Leemon McHenry, Jon Jureidini & Jay Amsterdam - 2016 - International Journal of Risk and Safety in Medicine 28:33-43.details
- At Law: FDA's Compassion for Desperate Drug Companies.George J. Annas - 1990 - Hastings Center Report 20 (1):35.details
- Confronting the Other.Peter Steinfels - 1972 - Hastings Center Report 2 (5):4.details
- Book Review: Prescription Drug Abuse and DependenceGreenfieldDaniel P., Ed., Prescription Drug Abuse and Dependence: How Prescription Drug Abuse Contributes to the Drug Abuse Epidemic : 170 Pp. [REVIEW]Bonnie B. Wilford - 1996 - Journal of Law, Medicine and Ethics 24 (1):62-64.details
- Recent Developments in Health Law: FDA and Drug Safety: New Tufts Study Challenges Critics of the Prescription Drug User Fee Act.Rochelle Lee - 2006 - Journal of Law, Medicine and Ethics 34 (1):131-134.details
- Pharmaceutical Firms and the Right to Health.Thana Cristina de Campos & Thomas Pogge - 2012 - Journal of Law, Medicine and Ethics 40 (2):183-187.details
- Institutional Corruption and the Pharmaceutical Policy.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):544-552.details
- ‘Drugs That Make You Feel Bad’? Remorse-Based Mitigation and Neurointerventions.Jonathan Pugh & Hannah Maslen - 2017 - Criminal Law and Philosophy 11 (3):499-522.details
- Demand for a Medicare Prescription Drug Benefit: Exploring Consumer Preferences Under a Managed Competition Framework.Richard R. Cline & David A. Mott - 2003 - Inquiry: The Journal of Health Care Organization, Provision, and Financing 40 (2):169-183.details
- Perverse Incentives in the Medicare Prescription Drug Benefit.David McAdams & Michael Schwarz - 2007 - Inquiry: The Journal of Health Care Organization, Provision, and Financing 44 (2):157-166.details
- Responding to Vulnerability: The Case of Injection Drug Use.Elizabeth Ben-Ishai - 2012 - International Journal of Feminist Approaches to Bioethics 5 (2):39-63.details
- Raising the Barriers to Access to Medicines in the Developing World – The Relentless Push for Data Exclusivity.Diependaele Lisa, Cockbain Julian & Sterckx Sigrid - 2017 - Developing World Bioethics 17 (1):11-21.details
- The Power of Pills: Social, Ethical & Legal Issues in Drug Development, Marketing & Pricing – Edited by Jillian C. Cohen, Patricia Illingworth & Udo Schüklenk.Steven Lewis - 2009 - Developing World Bioethics 9 (1):43-45.details
- Review of Leonard J. Weber, Profits Before People? Ethical Standards and the Marketing of Prescription Drugs.1. [REVIEW]Jerome P. Kassirer - 2007 - American Journal of Bioethics 7 (3):54-55.details
- The Physician and the Pharmaceutical Detail Man: An Ethical Analysis.Brian Kaatz & Jerome Freeman - 1987 - Journal of Medical Humanities 8 (1):34-39.details
- GlaxoSmithKline and Developing Country Access to Essential Medicines.N. Craig Smith & Anne Duncan - 2005 - Journal of Business Ethics Education 2 (1):97-121.details
- Trade Rules, Intellectual Property, and the Right to Health.Lisa Forman - 2007 - Ethics and International Affairs 21 (3):337-357.details
- Access to Medicines and the Rhetoric of Responsibility.Christian Barry & Kate Raworth - 2002 - Ethics and International Affairs 16 (2):57-70.details
- Pharmacists' and Doctors’ Perception of Pharmaceutical Representative’s Ethical Practices of Drug Promotion in Romania. A Comparative Study.Laszlo-Zoltan Sztankovszky, Camelia Soponaru, Magdalena Iorga & Vasile Astarastoae - 2015 - Postmodern Openings 6 (1):189-199.details
- Deadly Medicines and Organised Crime: How Big Pharma has Corrupted Healthcare by Peter Gøtzsche.Justin B. Biddle - 2016 - Kennedy Institute of Ethics Journal 26 (2):40-43.details
- Body-Self Dualism in Contemporary Ethics and Politics.Patrick Lee & Robert P. George - 2007 - Cambridge University Press.details
- Pharmaceutical Company Corruption and the Moral Crisis in Medicine.Sharon Batt - 2016 - Hastings Center Report 46 (4):10-13.details
- The Disposable Author:How Pharmaceutical Marketing Is Embraced Within Medicine's Scholarly Literature.Alastair Matheson - 2016 - Hastings Center Report 46 (4):31-37.details
- Roy Church and E. M. Tansey, Burroughs Wellcome & Co.: Knowledge, Trust and Profit, and the Transformation of the British Pharmaceutical Industry, 1880–1940. Lancaster: Crucible, 2007. Pp. Xxvii+564. ISBN 978-1-905-472-07-9. £19.99. [REVIEW]Claire Jones - 2009 - British Journal for the History of Science 42 (2):288.details
- Jonathan Liebenau. Medical Science and Medical Industry. The Formation of the American Pharmaceutical Industry. London: Macmillan, 1987. Pp Ix + 207. ISBN 0-333-41742-9, £29.50. - John P. Swann. Academic Scientists and the Pharmaceutical Industry. Cooperative Research in Twentieth Century America. Baltimore: The Johns Hopkins University Press, 1988. Pp Xi + 249. ISBN 0-8018-3558-5, £22.50. [REVIEW]Peter Morris - 1989 - British Journal for the History of Science 22 (4):442-444.details
- L ESLEY R ICHMOND, J ULIE S TEVENSON and A LISON T URTON , The Pharmaceutical Industry: A Guide to Historical Records. Aldershot: Ashgate, 2003. Pp. Ix+561. ISBN 0-7546-3352-7. £55.00. [REVIEW]Peter Morris - 2006 - British Journal for the History of Science 39 (1):144-145.details
- Academic Scientists and the Pharmaceutical Industry: Cooperative Research in Twentieth-Century America. John P. Swann.Leon Gortler - 1990 - Isis 81 (1):136-137.details
- Medical Science and Medical Industry: The Formation of the American Pharmaceutical Industry. Jonathan Liebenau.John P. Swann - 1988 - Isis 79 (3):521-523.details
- Old Drugs in New BottlesResearches in the History of Pharmaceutical ChemistryGerald Schröder Robert Bohlmann Winfred Schröder Dietrich Arends Erika Hickel Wolfgang Schneider Herbert Wietschoreck Bhulabhai Patel Christian Wehle Mechthild Krüger Horst Matthias Real.Robert P. Multhauf - 1972 - Isis 63 (3):408-412.details
- Feeling Is Believing: Evaluative Conditioning and the Ethics of Pharmaceutical Advertising.Paul Biegler & Patrick Vargas - 2016 - Journal of Bioethical Inquiry 13 (2):271-279.details
- Ethical Relation Between Physicians and Pharmaceutical Industries in the Perspectives of Bangladesh.Shahinul Alam, Nahiduz Saman, Monsur Hallaj Hallaj, Jahangir Ul Alam & Shoaib Momen Majumder - 2015 - Bangladesh Journal of Bioethics 6 (1):1-5.details
- Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine and Ethics 40 (2):220-233.details
- Drug Firms, the Codification of Diagnostic Categories, and Bias in Clinical Guidelines.Lisa Cosgrove & Emily E. Wheeler - 2013 - Journal of Law, Medicine and Ethics 41 (3):644-653.details
- Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability Under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine and Ethics 40 (2):234-250.details
- Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):654-664.details
- The Ethics of Pharmaceutical Research Funding: A Social Organization Approach.Garry C. Gray - 2013 - Journal of Law, Medicine and Ethics 41 (3):629-634.details
|
Off-campus access
Using PhilPapers from home?
Create an account to enable off-campus access through your institution's proxy server.
Monitor this page
Be alerted of all new items appearing on this page. Choose how you want to monitor it:
Email
|
RSS feed
|
|